81 FR 46086 - Request for Nominations on the Tobacco Products Scientific Advisory Committee

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 81, Issue 136 (July 15, 2016)

Page Range		46086-46087
FR Document		2016-16739

The Food and Drug Administration (FDA) is requesting that any industry organizations interested in participating in the selection of a nonvoting industry representative of the tobacco manufacturing industry to serve on the Tobacco Products Scientific Advisory Committee for the Center for Tobacco Products (CTP), notify FDA in writing. FDA is also requesting nominations for a nonvoting industry representative of the tobacco manufacturing industry to serve on the Tobacco Products Scientific Advisory Committee, and an alternate to this representative. A nominee may either be self-nominated or nominated by an organization to serve as a nonvoting industry representative. Nominations will be accepted for current vacancies effective with this notice.

Federal Register, Volume 81 Issue 136 (Friday, July 15, 2016)

[Federal Register Volume 81, Number 136 (Friday, July 15, 2016)]
[Notices]
[Pages 46086-46087]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-16739]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2016-N-1984]


Request for Nominations on the Tobacco Products Scientific 
Advisory Committee

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting that any 
industry organizations interested in participating in the selection of 
a nonvoting industry representative of the tobacco manufacturing 
industry to serve on the Tobacco Products Scientific Advisory Committee 
for the Center for Tobacco Products (CTP), notify FDA in writing. FDA 
is also requesting nominations for a nonvoting industry representative 
of the tobacco manufacturing industry to serve on the Tobacco Products 
Scientific Advisory Committee, and an alternate to this representative. 
A nominee may either be self-nominated or nominated by an organization 
to serve as a nonvoting industry representative. Nominations will be 
accepted for current vacancies effective with this notice.

DATES: Any industry organization interested in participating in the 
selection of an appropriate nonvoting member to represent industry 
interests must send a letter stating that interest to the FDA by August 
15, 2016 (see sections I and II of this document for further details). 
Concurrently, nomination materials for prospective candidates should be 
sent to FDA by August 15, 2016.

ADDRESSES: All statements of interest from industry organizations 
interested in participating in the selection process should be sent to 
Caryn Cohen (see FOR FURTHER INFORMATION CONTACT). All nominations for 
nonvoting industry representatives should be submitted electronically 
by accessing the FDA Advisory Committee Membership Nomination Portal: 
https://www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm or 
by mail to Advisory Committee Oversight and Management Staff, Food and 
Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 5103, 
Silver Spring, MD 20993-0002. Information about becoming a member of an 
FDA advisory committee can also be obtained by visiting FDA's Web site 
http://www.fda.gov/AdvisoryCommittees/default.htm.

FOR FURTHER INFORMATION CONTACT: Caryn Cohen, Office of Science, Center 
for Tobacco Products, Food and Drug Administration, Center for Tobacco 
Products Document Control Center, Bldg. 71, Rm. G335, 10903 New 
Hampshire Ave., Silver Spring, MD 20993-0002, 1-877-287-1373 (choose 
Option 5), email: [email protected].

SUPPLEMENTARY INFORMATION: The Agency intends to add nonvoting industry 
representatives to the following advisory committee.

I. CTP Advisory Committee, Tobacco Products Scientific Advisory 
Committee

    The Tobacco Products Scientific Advisory Committee (the Committee) 
advises the Commissioner of Food and Drugs (the Commissioner) or 
designee in discharging responsibilities related to the regulation of 
tobacco products. The Committee reviews and evaluates safety, 
dependence, and health issues relating to tobacco products and provides 
appropriate advice, information, and recommendations to the 
Commissioner.

II. Selection Procedure

    Any industry organization interested in participating in the 
selection of an appropriate nonvoting member to represent industry 
interests should send a letter stating that interest to the FDA contact 
(see FOR FURTHER INFORMATION CONTACT) within 30 days of publication of 
this document (see DATES). Within the subsequent 30 days, FDA will send 
a letter to each organization that has expressed an interest, attaching 
a complete list of all such organizations and a list of all nominees 
along with their current resumes. The letter will also state that it is 
the responsibility of the interested organizations to confer with one 
another and to select a candidate, within 60 days after the receipt of 
the FDA letter, to serve as the nonvoting member to represent industry 
interests for the committee. The interested organizations are not bound 
by the list of nominees in selecting a candidate. However, if no 
individual is selected within 60 days, the Commissioner will select the 
nonvoting member to represent industry interests.

III. Application Procedure

    Individuals may self-nominate and/or an organization may nominate 
one or more individuals to serve as a nonvoting industry 
representative. Contact information, current curriculum vitae, and the 
name of the committee of interest should be sent to the FDA Advisory 
Committee Membership Nomination Portal (see ADDRESSES) within 30 days 
of publication of this document (see DATES). FDA will forward all 
nominations to the organizations expressing interest in participating 
in the selection process for the committee. (Persons who nominate 
themselves as nonvoting industry representatives will not participate 
in the selection process.)
    FDA seeks to include the views of women and men, members of all 
racial and ethnic groups, and individuals with and without disabilities 
on its advisory committees and, therefore, encourages

[[Page 46087]]

nominations of appropriately qualified candidates from these groups.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

     Dated: July 11, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-16739 Filed 7-14-16; 8:45 am]
 BILLING CODE 4164-01-P

46086 Federal Register / Vol. 81, No. 136 / Friday, July 15, 2016 / Notices

fda.hhs.gov to receive an electronic ACTION: Notice. industry representatives to the following
copy of the document. Please use the advisory committee.
document number 1400027 to identify SUMMARY: The Food and Drug
Administration (FDA) is requesting that I. CTP Advisory Committee, Tobacco
the guidance you are requesting.
any industry organizations interested in Products Scientific Advisory Committee
IV. Paperwork Reduction Act of 1995 participating in the selection of a The Tobacco Products Scientific
This draft guidance refers to nonvoting industry representative of the Advisory Committee (the Committee)
previously approved collections of tobacco manufacturing industry to serve advises the Commissioner of Food and
information found in FDA regulations on the Tobacco Products Scientific Drugs (the Commissioner) or designee in
and guidance documents. These Advisory Committee for the Center for discharging responsibilities related to
collections of information are subject to Tobacco Products (CTP), notify FDA in the regulation of tobacco products. The
review by the Office of Management and writing. FDA is also requesting Committee reviews and evaluates safety,
Budget (OMB) under the Paperwork nominations for a nonvoting industry dependence, and health issues relating
Reduction Act of 1995 (44 U.S.C. 3501– representative of the tobacco to tobacco products and provides
3520). The collections of information in manufacturing industry to serve on the appropriate advice, information, and
21 CFR parts 801 and 809 have been Tobacco Products Scientific Advisory recommendations to the Commissioner.
approved under OMB control number Committee, and an alternate to this II. Selection Procedure
0910–0485; the collections of representative. A nominee may either be
information in parts 50 and 56 have self-nominated or nominated by an Any industry organization interested
been approved under OMB control organization to serve as a nonvoting in participating in the selection of an
number 0910–0130; the collections of industry representative. Nominations appropriate nonvoting member to
information in 21 CFR part 812 have will be accepted for current vacancies represent industry interests should send
been approved under OMB control effective with this notice. a letter stating that interest to the FDA
number 0910–0078; the collections of contact (see FOR FURTHER INFORMATION
DATES: Any industry organization CONTACT) within 30 days of publication
information in 21 CFR part 814 subparts interested in participating in the
B and E have been approved under of this document (see DATES). Within the
selection of an appropriate nonvoting subsequent 30 days, FDA will send a
OMB control number 0910–0231; the member to represent industry interests
collections of information in 21 CFR letter to each organization that has
must send a letter stating that interest to expressed an interest, attaching a
part 814, subpart H, have been approved the FDA by August 15, 2016 (see
under OMB control number 0910–0332; complete list of all such organizations
sections I and II of this document for and a list of all nominees along with
the collections of information in 21 CFR further details). Concurrently,
part 807, subpart E, have been approved their current resumes. The letter will
nomination materials for prospective also state that it is the responsibility of
under OMB control number 0901–0120; candidates should be sent to FDA by
the collections of information in 21 CFR the interested organizations to confer
August 15, 2016. with one another and to select a
part 820 have been approved under
ADDRESSES: All statements of interest candidate, within 60 days after the
OMB control number 0910–0073; the
from industry organizations interested receipt of the FDA letter, to serve as the
collections of information in 21 CFR
in participating in the selection process nonvoting member to represent industry
part 601 have been approved under
should be sent to Caryn Cohen (see FOR interests for the committee. The
OMB control number 0910–0338; the
FURTHER INFORMATION CONTACT). All interested organizations are not bound
collections of information in 21 CFR
nominations for nonvoting industry by the list of nominees in selecting a
part 312 have been approved under
representatives should be submitted candidate. However, if no individual is
OMB control number 0910–0014; the
electronically by accessing the FDA selected within 60 days, the
collections of information in 21 CFR
Advisory Committee Membership Commissioner will select the nonvoting
part 314 have been approved under
Nomination Portal: https:// member to represent industry interests.
OMB control number 0910–0001; and
www.accessdata.fda.gov/scripts/
the collections of information resulting III. Application Procedure
FACTRSPortal/FACTRS/index.cfm or by
from special protocol assessments have Individuals may self-nominate and/or
mail to Advisory Committee Oversight
been approved under OMB control an organization may nominate one or
and Management Staff, Food and Drug
number 0910–0470. more individuals to serve as a nonvoting
Administration, 10903 New Hampshire
Dated: July 11, 2016. Ave., Bldg. 32, Rm. 5103, Silver Spring, industry representative. Contact
Leslie Kux, MD 20993–0002. Information about information, current curriculum vitae,
Associate Commissioner for Policy. becoming a member of an FDA advisory and the name of the committee of
[FR Doc. 2016–16735 Filed 7–14–16; 8:45 am] committee can also be obtained by interest should be sent to the FDA
BILLING CODE 4164–01–P visiting FDA’s Web site http:// Advisory Committee Membership
www.fda.gov/AdvisoryCommittees/ Nomination Portal (see ADDRESSES)
default.htm. within 30 days of publication of this
DEPARTMENT OF HEALTH AND document (see DATES). FDA will forward
FOR FURTHER INFORMATION CONTACT: all nominations to the organizations
HUMAN SERVICES
Caryn Cohen, Office of Science, Center expressing interest in participating in
Food and Drug Administration for Tobacco Products, Food and Drug the selection process for the committee.
Administration, Center for Tobacco
sradovich on DSK3GMQ082PROD with NOTICES

(Persons who nominate themselves as
[Docket No. FDA–2016–N–1984] Products Document Control Center, nonvoting industry representatives will
Bldg. 71, Rm. G335, 10903 New not participate in the selection process.)
Request for Nominations on the Hampshire Ave., Silver Spring, MD
Tobacco Products Scientific Advisory FDA seeks to include the views of
20993–0002, 1–877–287–1373 (choose women and men, members of all racial
Committee Option 5), email: TPSAC@fda.hhs.gov. and ethnic groups, and individuals with
AGENCY: Food and Drug Administration, SUPPLEMENTARY INFORMATION: The and without disabilities on its advisory
HHS. Agency intends to add nonvoting committees and, therefore, encourages

VerDate Sep<11>2014 19:03 Jul 14, 2016 Jkt 238001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\15JYN1.SGM 15JYN1

Document Created: 2016-07-15 02:53:34
Document Modified: 2016-07-15 02:53:34

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Dates		Any industry organization interested in participating in the selection of an appropriate nonvoting member to represent industry interests must send a letter stating that interest to the FDA by August 15, 2016 (see sections I and II of this document for further details). Concurrently, nomination materials for prospective candidates should be sent to FDA by August 15, 2016.
Contact		Caryn Cohen, Office of Science, Center for Tobacco Products, Food and Drug Administration, Center for Tobacco Products Document Control Center, Bldg. 71, Rm. G335, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, 1-877-287-1373 (choose Option 5), email: [email protected]
FR Citation		81 FR 46086

81 FR 46086 - Request for Nominations on the Tobacco Products Scientific Advisory Committee

DEPARTMENT OF HEALTH AND HUMAN SERVICESFood and Drug Administration

Federal Register Volume 81, Issue 136 (July 15, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration